뒤로
Bavarian Nordic A/S (BVNRY) 수입
BVNRY 주가 차트
BVNRY 수입
Bavarian Nordic A/S
$9.76
0.93%
$0.08
오늘 기준:Mar 30, 12:27:46 GMT-4
최신 수익 결과: Q4 '25
보고됨: 2026-03-12
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
BVNRY의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Bavarian Nordic A/S BVNRY의 지난 분기 매출 실적은 어땠나요?
Bavarian Nordic A/S의 매출 추정치는 얼마인가요?
Bavarian Nordic A/S의 수익 품질 점수는 얼마인가요?
Bavarian Nordic A/S는 언제 수익을 보고하나요?
Bavarian Nordic A/S의 예상 수익은 얼마인가요?
Bavarian Nordic A/S은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$9.67
시가
$9.76
일일 범위
$9.76 - $9.76
52주 범위
$6.59 - $13
거래량
2
평균 거래량
1.6K
배당수익률
--
EPS(TTM)
0.91
시가총액
$2.2B
Bavarian Nordic A/S란 무엇인가요?
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in research and development innovations, production and commercialization of life-saving vaccines based on viral vectors for the delivery of antigens targeting infectious diseases. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The firm deals with vaccines aimed at improving public health and preparedness. Bavarian Nordic A/S focuses on vaccine solutions that help address the threat of infectious diseases. The firm operates worldwide.